TACE (ADAM-17) Peptide

Este producto es parte de ADAM17 - ADAM metallopeptidase domain 17
TACE (ADAM-17) Peptide
221€ (1 mg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
TACE (ADAM-17) Peptide
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx266764

Description

TACE (ADAM-17) is a peptide.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
TACE (ADAM-17)
Conjugation
Unconjugated
Observed MW
1768.91 Da
Purity
> 95% (HPLC)
Size 1
1 mg
Size 2
5 mg
Size 3
10 mg
Form
Lyophilized
Buffer
Not applicable.
Availability
Shipped within 10-20 working days.
Storage
Store dry at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
CSVP, CD156B, TACE,TNF-Alpha Convertase,TNF-Alpha Converting enzyme,adam-17
Background
Protein ADAM17
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

ADAM17, also known as ADAM metallopeptidase domain 17 or tumor necrosis factor-alpha converting enzyme (TACE), is a member of the ADAM family of proteins. Like other ADAM proteins, it possesses a complex domain structure with distinct functional regions, including a metalloproteinase domain responsible for its proteolytic activity.ADAM17 is a transmembrane protein. Consists of several domains, including a metalloproteinase domain, a disintegrin domain, a cysteine-rich domain, an EGF-like domain, a transmembrane domain, and a cytoplasmic tail. Is responsible for the cleavage and release of various membrane-bound proteins, including cytokines, growth factors, receptors, and adhesion molecules. One of its most well-known substrates is tumor necrosis factor-alpha (TNF-α).ADAM17 cleaves the membrane-bound precursor form of TNF-α to release its soluble form into the extracellular space. Soluble TNF-α can then bind to its receptors on target cells, initiating signaling cascades involved in inflammation, apoptosis, and immune responses.ADAM17 also sheds and regulates the activity of other important proteins, including epidermal growth factor receptor (EGFR) ligands, transforming growth factor-alpha (TGF-α), and Notch receptor. Dysregulation of ADAM17 activity has been implicated in various diseases, including inflammatory disorders, autoimmune diseases, cancer, and cardiovascular diseases. In particular, increased ADAM17 activity and elevated levels of its substrates, such as TNF-α, have been observed in conditions like rheumatoid arthritis, inflammatory bowel disease, and certain cancers. Given its central role in inflammation and disease pathogenesis, ADAM17 is considered a promising therapeutic target

Productos relacionados

abx000869

ADAM Metallopeptidase Domain 17 (ADAM17) Antibody

ADAM17 Antibody is a Rabbit Polyclonal antibody against ADAM17. The ADAMs (A Disintegrin And Metalloprotease) are multid…

Ver producto
abx015548

A Disintegrin And Metalloprotease 17 Cleaved-Arg215 (ADAM17 Cleaved-R215) Antibody

Rabbit polyclonal antibody against ADAM 17 protein. Immunogen region is Internal. Specificity is as follows for the reac…

Ver producto
abx028423

ADAM Metallopeptidase Domain 17 (ADAM17) Antibody

ADAM17 is a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-an…

Ver producto